Navigation Links
Sonus Pharmaceuticals and OncoGenex Technologies to Merge
Date:5/28/2008

e asked to call the above numbers approximately 5-10 minutes prior to the start time. Additionally, the call will be broadcast live and can be accessed on the Sonus web site at http://ir.sonuspharma.com/events.cfm. A telephone replay of the call will be available from May 28, 2:00 p.m. Pacific Time, for three business days at 800-405-2236 or 303-590-3000 for international calls; Conference ID: 11114594 followed by the number sign.

Additional Information

As previously announced on November 5, 2007, Sonus received notification from the staff of The NASDAQ Stock Market indicating that the company is not in compliance with the $1.00 minimum bid price requirement for continued listing under Marketplace Rule 4450(a)(5). Sonus announced on May 8, 2008, that it had received a Determination Letter from NASDAQ indicating that the company had failed to regain compliance and is therefore to be delisted from The NASDAQ Global Market. Sonus has requested a hearing before a NASDAQ Listing Qualifications Panel to appeal NASDAQ's determination and intends to seek continued listing of its common stock. As part of its plan of compliance, Sonus also intends to effect a reverse stock split, subject to stockholder approval. Subject to NASDAQ's determination, Sonus intends to submit an application to change the ticker symbol to "OGXI" following consummation of the merger.

About Sonus Pharmaceuticals, Inc.

Headquartered near Seattle, Washington, Sonus Pharmaceuticals, Inc. is focused on the development of cancer drugs that are designed to provide better efficacy, safety and tolerability, and ease of use. Sonus moved an oncology product candidate, SN2310, into a Phase 1 clinical trial in September 2006. For additional information on Sonus, including past news releases, please visit http://www.sonuspharma.com.

About OncoGenex Technologies
'/>"/>

SOURCE OncoGenex Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
2. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
3. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
4. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
5. VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors
6. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
7. Takeda Pharmaceuticals Establishes $3 Million Endowment with AGA Foundation
8. MAP Pharmaceuticals to Present at the 2008 Citi Investment Research Global Healthcare Conference
9. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
10. Transdel Pharmaceuticals Closes $4 Million Financing
11. XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 ... throughput research solutions, today announced that Lupin Limited, ... received delivery of Freeslate’s CM Protégé PharmD ... , Lupin, headquartered in Mumbai, India, is ... generic and branded formulations and Active Pharmaceutical Ingredients ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 ... they have signed an exclusive agreement with R-Pharm, ... commercialize nemonoxacin (Taigexyn ® ) in the ... and other members of the Commonwealth ... the treatment of bacterial infections including those caused ...
(Date:1/14/2014)... Washington, DC (PRWEB) January 14, 2014 ... a webcast session for Thursday, January 23, 2014 ... Converting Raw Data into Actionable Knowledge.” The topic ... data into actionable knowledge to drive mission critical ... last approximately one hour. , Synopsis: Big Data ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2
... To validate any RNAi experiment, target mRNA , ... using a positive control siRNA that is known to be effective, , ... , Validation is also necessary ... effectiveness and potency of any siRNA sequence. Finally, , ...
... Microarrays , ... engineered to maximize yields of full-length cDNA , ... 100 ng of input RNA in a single round for GeneChip , ... cRNA synthesis powered by , MEGAscript, the best ...
... Total RNA Isolation from Formalin Fixed Paraffin Embedded (FFPE) Tissues , ... Phenol-free isolation of total RNA from , FFPE tissues , ... href="http://www.ambiondx.com/products/optimum/index.html">Optimum , ... and rapid protocol , for ...
Cached Biology Technology:Confirming RNAi Effects Is Now Easier Than Ever 2Confirming RNAi Effects Is Now Easier Than Ever 3Confirming RNAi Effects Is Now Easier Than Ever 4Confirming RNAi Effects Is Now Easier Than Ever 5Improving RNA Amplification 2Improving RNA Amplification 3Improving RNA Amplification 4Improving RNA Amplification 5Improving RNA Amplification 6Improving RNA Amplification 7Improving RNA Amplification 8Improving RNA Amplification 9Improving RNA Amplification 10Improving RNA Amplification 11Improving RNA Amplification 12Improving RNA Amplification 13Improving RNA Amplification 14Optimum FFPE RNA Isolation Kit 2Optimum FFPE RNA Isolation Kit 3Optimum FFPE RNA Isolation Kit 4
(Date:4/16/2014)... Professor Nicolas Doucet of the Centre INRSInstitut Armand-Frappier has ... of Health (NIH) in the amount of nearly US$600,000. ... the workings of tiny proteins called RNases and to ... as well as in inflammation and asthma. ... accomplishment in itself," said Yves Bgin, vice president of ...
(Date:4/16/2014)... border" a densely packed array of finger-like ... the cells that line our intestines., Vanderbilt University ... this specialized structure, which is critical for absorbing ... April 10 in the journal Cell , ... border assembly and increase our understanding of intestinal ...
(Date:4/16/2014)... ability to store memories improves during childhood, associated ... connections with prefrontal and parietal cortices. New research ... regions develop at this crucial time. Eventually, that ... in the transition into and during adolescence and ... Located deep in the middle of the brain, ...
Breaking Biology News(10 mins):High-level NIH grant goes to professor Nicolas Doucet of INRS 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 3How kids' brain structures grow as memory develops 2
... Combining the expertise of several different labs, University of Iowa ... eye disease retinitis pigmentosa (RP) and, in the process, discovered ... the affected protein. The study, which was published online ... of Sciences (PNAS) Early Edition, suggests that the mutation ...
... LANSING, Mich. --- Farmers and policymakers should wait before converting ... to a Michigan State University study. The study, ... of the National Academy of Sciences , focuses on CRP ... cover rather than crops, and its role in the production ...
... streams and wetlands are not isolated ecosystems, and a ... a new field of research to show just how ... associate professor of fisheries and wildlife, has netted a ... use and climate change,s impact on freshwater ecosystems, and ...
Cached Biology News:U. Iowa research team finds new genetic cause of blinding eye disease 2U. Iowa research team finds new genetic cause of blinding eye disease 3To avoid carbon debt, CRP beats fields of corn, soybeans 2MSU professor launches new field of water research, nets $2.2 million NSF grant 2
... microRNA expression profiling and built on ... on-chip synthesis platform. These microarrays are ... microRNA Expression Profiling Service. ... Microarray contains all known arabidopsis microRNAs ...
... Microarrays designed for genome-wide microRNA expression ... and powerful Paraflo microfluidic on-chip synthesis ... part of our comprehensive microRNA Expression ... The Viruses microRNA Microarray contains ...
... Networked GC is an excellent choice for supporting ... standard dual-channel GC, this one-channel workhorse can double ... space of one. You get all the capability ... in an instrument that has the same proven ...
... laboratory animal infusion kits reduce the time ... study while providing sterile equipment to reduce ... everything you need for one animal, including ... tethers will be cut to the exact ...
Biology Products: